Researchers develop structural blueprint of nanoparticles to target white blood cells responsible for lung inflammation
The COVID-19 pandemic highlighted the devastating impact of acute lung inflammation (ALI), which is part of the acute respiratory distress syndrome (ARDS) that is the dominant cause of death in COVID-19. A potential new route ...